FR2292477A1 - Derives de 1-amidoalkyl-4-sulfonyl-piperazine, leur procede d'obtention et medicaments contenant lesdits derives - Google Patents

Derives de 1-amidoalkyl-4-sulfonyl-piperazine, leur procede d'obtention et medicaments contenant lesdits derives

Info

Publication number
FR2292477A1
FR2292477A1 FR7530224A FR7530224A FR2292477A1 FR 2292477 A1 FR2292477 A1 FR 2292477A1 FR 7530224 A FR7530224 A FR 7530224A FR 7530224 A FR7530224 A FR 7530224A FR 2292477 A1 FR2292477 A1 FR 2292477A1
Authority
FR
France
Prior art keywords
derivatives
amidoalkyl
piperazine
sulfonyl
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7530224A
Other languages
English (en)
Other versions
FR2292477B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Liade SA
Original Assignee
Laboratorios Liade SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Liade SA filed Critical Laboratorios Liade SA
Publication of FR2292477A1 publication Critical patent/FR2292477A1/fr
Application granted granted Critical
Publication of FR2292477B1 publication Critical patent/FR2292477B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FR7530224A 1974-11-27 1975-10-02 Derives de 1-amidoalkyl-4-sulfonyl-piperazine, leur procede d'obtention et medicaments contenant lesdits derives Granted FR2292477A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES432334A ES432334A1 (es) 1974-11-27 1974-11-27 Procedimiento de obtencion de derivados 1-amido alquil-4- sulfonil-piperazina.

Publications (2)

Publication Number Publication Date
FR2292477A1 true FR2292477A1 (fr) 1976-06-25
FR2292477B1 FR2292477B1 (fr) 1979-09-14

Family

ID=8468076

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7530224A Granted FR2292477A1 (fr) 1974-11-27 1975-10-02 Derives de 1-amidoalkyl-4-sulfonyl-piperazine, leur procede d'obtention et medicaments contenant lesdits derives

Country Status (5)

Country Link
JP (1) JPS5165778A (fr)
CH (1) CH605833A5 (fr)
DE (1) DE2545329A1 (fr)
ES (1) ES432334A1 (fr)
FR (1) FR2292477A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533240A2 (fr) * 1991-09-16 1993-03-24 Merck & Co. Inc. Dérivés substitués par amino de pipérazin-camphre sulfonylé comme antagonistes d'oxytocine
EP0533242A2 (fr) * 1991-09-16 1993-03-24 Merck & Co. Inc. Dérivés substitués du pipérazin-camphre sulfonylé comme antagonistes d'oxytocine
EP0533241A2 (fr) * 1991-09-16 1993-03-24 Merck & Co. Inc. Dérivés de pipérazin-camphre sulfonylé substitués par alcoyle comme antagonistes d'oxytocine
US5464788A (en) * 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5648352A (en) * 1991-09-13 1997-07-15 Merck & Co., Inc. Piperazinylcamphorsulfonyl oxytocin antagonists
US5665719A (en) * 1993-07-16 1997-09-09 Merck & Co., Inc. Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
US5686454A (en) * 1993-07-16 1997-11-11 Merck & Co., Inc. Camphorcarbonyl

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56157809U (fr) * 1980-04-24 1981-11-25
KR20010025140A (ko) * 2000-02-11 2001-04-06 남홍길 보르네올 또는 캄포를 유효성분으로 하는 니코틴 수용체길항제

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081346A1 (en) * 1969-12-12 1971-12-03 Liade Sa Lab 1-benzamidoalkyl-4-camphorsulphonyl- - piperazines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081346A1 (en) * 1969-12-12 1971-12-03 Liade Sa Lab 1-benzamidoalkyl-4-camphorsulphonyl- - piperazines

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648352A (en) * 1991-09-13 1997-07-15 Merck & Co., Inc. Piperazinylcamphorsulfonyl oxytocin antagonists
EP0533240A2 (fr) * 1991-09-16 1993-03-24 Merck & Co. Inc. Dérivés substitués par amino de pipérazin-camphre sulfonylé comme antagonistes d'oxytocine
EP0533242A2 (fr) * 1991-09-16 1993-03-24 Merck & Co. Inc. Dérivés substitués du pipérazin-camphre sulfonylé comme antagonistes d'oxytocine
EP0533241A2 (fr) * 1991-09-16 1993-03-24 Merck & Co. Inc. Dérivés de pipérazin-camphre sulfonylé substitués par alcoyle comme antagonistes d'oxytocine
EP0533242A3 (en) * 1991-09-16 1993-09-15 Merck & Co. Inc. Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
EP0533240A3 (en) * 1991-09-16 1993-09-29 Merck & Co. Inc. Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
EP0533241A3 (en) * 1991-09-16 1993-09-29 Merck & Co. Inc. Substituted alkyl derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
US5665719A (en) * 1993-07-16 1997-09-09 Merck & Co., Inc. Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
US5686454A (en) * 1993-07-16 1997-11-11 Merck & Co., Inc. Camphorcarbonyl
US5464788A (en) * 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5756504A (en) * 1994-03-24 1998-05-26 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists

Also Published As

Publication number Publication date
FR2292477B1 (fr) 1979-09-14
JPS5165778A (en) 1976-06-07
CH605833A5 (fr) 1978-10-13
JPS541317B2 (fr) 1979-01-23
DE2545329A1 (de) 1976-08-12
ES432334A1 (es) 1976-11-01

Similar Documents

Publication Publication Date Title
BE827354A (fr) Nouveaux derives benzamidiques de pyrrolidine et piperidine, leur procede de preparation et medicament les contenant
FR2293928A1 (fr) Nouveaux derives d'acide 3-amino-indazolecarboxylique, leur procede de preparation et medicament les contenant
FR2334359A1 (fr) Derives de l'isoquinoleine, leur preparation et medicaments contenant ces substances
BE768137A (fr) Derives de piperazinyl-alcoyl-quinazolone-(4), leur procede de preparation et medicaments en contenant
BE826900A (fr) Nouveaux derives 1-(4-phenoxy-phenyl)-1,3,5 triaziniques, leur triaziniques procede de preparation et medicament les contenant
BE829052A (fr) Nouvelles phenylguanidines substituees, leur procede de preparation et medicament les contenant
BE829758A (fr) Nouveaux derives de cephalosporine, leur procede de preparation et medicaments les contenant
FR2297037A1 (fr) Nouveaux derives de biphenyloxy, medicaments les contenant et procede pour leur preparation
BE755924A (fr) Derives d'acide pyrazole-4-acetique, leur procede de preparation et medicaments en contenant
FR2287916A1 (fr) Nouveaux derives dipeptidiques, leur procede de preparation et medicament les contenant
BE828430A (fr) Phenylalcoylamines, leur procede d'obtention et leur application commemedicaments
FR2344531A1 (fr) Nouveaux derives de l'acide sulfonamidobenzoique, leur procede de preparation et medicaments les contenant
FR2338938A1 (fr) Nouveaux derives de la piperazine et de ses homologues, leur procede de preparation et medicament les contenant
BE876297A (fr) Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant
FR2292477A1 (fr) Derives de 1-amidoalkyl-4-sulfonyl-piperazine, leur procede d'obtention et medicaments contenant lesdits derives
FR2290897A1 (fr) Nouveaux derives d'aminopropanol, leur procede de preparation et des medicaments les contenant
FR2339397A1 (fr) Nouveaux ethers d'oximes, procede de preparation de ceux-ci et medicaments les contenant
BE831421A (fr) Nouvelles phenylisothiourees substituees, leur procede de preparation et medicament les contenant
BE858781A (fr) Nouveaux derives 1,4-dihydropyridiques de sucres, leur procede de preparation et medicament les contenant
BE864644A (fr) Nouveaux derives de prostaglandines, leur procede de preparation et medicaments les contenant
BE860709A (fr) Nouveaux derives substitues de 0-phenylenediamine, leur procede de preparation et medicament les contenant
BE825245A (fr) Nouvelles 2-amino-6-dialkylaminodihydropyridines leur procede de preparation et medicament les contenant
BE835763A (fr) Nouveaux derives de quinoxaline-1,4-dioxyde, procede de preparation de ces derives et medicaments les contenant
FR2291753A1 (fr) Nouveau derive de 5,7-dihydroxy-tetrahydroisoquinoleine, son procede de preparation et medicament le contenant
BE836022A (fr) Nouveaux antibiotiques du type beta-lactame, leur procede de preparation et medicament les contenant

Legal Events

Date Code Title Description
ST Notification of lapse